Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer
- PMID: 38515297
- PMCID: PMC11046028
- DOI: 10.1097/CM9.0000000000003101
Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer
Abstract
Background: Gastric cancer is one of the most common malignant tumors in the digestive system in China. Few comprehensive practice guidelines for early gastric cancer in China are currently available. Therefore, we created the Chinese national clinical practice guideline for the prevention, diagnosis, and treatment of early gastric cancer.
Methods: This clinical practice guideline (CPG) was developed in accordance with the World Health Organization's recommended process and with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) in assessing evidence quality. We used the Evidence to Decision framework to formulate clinical recommendations to minimize bias and increase transparency in the CPG development process. We used the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement and the Appraisal of Guidelines for Research and Evaluation II (AGREE II) as reporting and conduct guidelines to ensure completeness and transparency of the CPG.
Results: This CPG contains 40 recommendations regarding the prevention, screening, diagnosis, treatment, and follow-up of early gastric cancer based on available clinical studies and guidelines. We provide recommendations for the timing of Helicobacter pylori eradication, screening populations for early gastric cancer, indications for endoscopic resection and surgical gastrectomy, follow-up interval after treatment, and other recommendations.
Conclusions: This CPG can lead to optimum care for patients and populations by providing up-to-date medical information. We intend this CPG for widespread adoption to increase the standard of prevention, screening, diagnosis, treatment, and follow-up of early gastric cancer; thereby, contributing to improving national health care and patient quality of life.
Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
Conflict of interest statement
None.
Similar articles
-
2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment.Chin Med J (Engl). 2022 Dec 20;135(24):2899-2910. doi: 10.1097/CM9.0000000000002546. Chin Med J (Engl). 2022. PMID: 36579940 Free PMC article.
-
Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer.Korean J Intern Med. 2013 Sep;28(5):525-37. doi: 10.3904/kjim.2013.28.5.525. Epub 2013 Aug 14. Korean J Intern Med. 2013. PMID: 24009446 Free PMC article. Review.
-
[Systematic review of methodological quality and reporting quality in gastric cancer screening guidelines].Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 6;54(3):314-319. doi: 10.3760/cma.j.issn.0253-9624.2020.03.013. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32187938 Chinese.
-
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.Gut. 2020 Dec;69(12):2093-2112. doi: 10.1136/gutjnl-2020-322368. Epub 2020 Oct 1. Gut. 2020. PMID: 33004546
-
[Quality assessment of guidelines on upper gastrointestinal cancer screening].Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jul 10;42(7):1318-1324. doi: 10.3760/cma.j.cn112338-20200805-01023. Zhonghua Liu Xing Bing Xue Za Zhi. 2021. PMID: 34814550 Chinese.
References
-
- Zong L, Abe M, Seto Y, Ji J. The challenge of screening for early gastric cancer in China. Lancet 2016;388:2606. doi: 10.1016/S0140-6736(16)32226-7. - PubMed
-
- Allemani C Weir HK Carreira H Harewood R Spika D Wang XS, et al. . Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385:977–1010. doi: 10.1016/S0140-6736(14)62038-9. - PMC - PubMed
-
- Alonso-Coello P Oxman AD Moberg J Brignardello-Petersen R Akl EA Davoli M, et al. . GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ 2016;353:i2089. doi: 10.1136/bmj.i2089. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical